How Much?! AbbVie (ABBV) Raises Niaspan Price Despite Study Failures
5/24/2013 7:49:00 AM
More...
|
AbbVie (ABBV) Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients With Diabetic Nephropathy
5/20/2013 10:56:48 AM
More...
|
AbbVie (ABBV), Galapagos NV (GLPG.BR) Galapagos Ink $50 Million Crohn's Disease Pact
5/17/2013 9:17:50 AM
More...
|
AbbVie (ABBV) to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
5/16/2013 7:35:31 AM
More...
|
Alvine Pharmaceuticals, Inc. Lands $70 Million From AbbVie (ABBV) for Celiac Disease Drug
5/14/2013 10:09:01 AM
More...
|
AbbVie (ABBV) and Alvine Pharmaceuticals, Inc. to Collaborate on Investigational Oral Therapy for Celiac Disease
5/14/2013 9:50:35 AM
More...
|
A Culture Change? AbbVie (ABBV) R&D to Retire
5/13/2013 10:12:25 AM
More...
|
AbbVie (ABBV) to Present at Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/7/2013 7:29:14 AM
More...
|
AbbVie (ABBV)'s Investigational HCV Regimen Receives Breakthrough Therapy Designation From the FDA
5/6/2013 10:10:32 AM
More...
|
AbbVie (ABBV)'s Investigational HCV Regimen Receives Breakthrough Therapy Designation
5/6/2013 7:45:33 AM
More...
|
|